Thomas M. Durcan

10.1k total citations
99 papers, 2.3k citations indexed

About

Thomas M. Durcan is a scholar working on Molecular Biology, Neurology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Thomas M. Durcan has authored 99 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 55 papers in Molecular Biology, 34 papers in Neurology and 22 papers in Cellular and Molecular Neuroscience. Recurrent topics in Thomas M. Durcan's work include Parkinson's Disease Mechanisms and Treatments (22 papers), Pluripotent Stem Cells Research (20 papers) and Mitochondrial Function and Pathology (11 papers). Thomas M. Durcan is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (22 papers), Pluripotent Stem Cells Research (20 papers) and Mitochondrial Function and Pathology (11 papers). Thomas M. Durcan collaborates with scholars based in Canada, United States and United Kingdom. Thomas M. Durcan's co-authors include Edward A. Fon, Matthew Y. H. Tang, Gian‐Luca McLelland, Jean‐François Trempe, Miguel Aguileta, Mathilde Chaineau, Lenore K. Beitel, Thomas A. Shaler, Benoit Coulombe and Denis Faubert and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Genes & Development.

In The Last Decade

Thomas M. Durcan

81 papers receiving 2.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thomas M. Durcan Canada 23 1.5k 831 573 379 340 99 2.3k
Zheng Ying China 25 1.1k 0.7× 560 0.7× 698 1.2× 279 0.7× 264 0.8× 72 2.0k
Tomohiro Kabuta Japan 26 1.1k 0.8× 713 0.9× 625 1.1× 245 0.6× 401 1.2× 55 2.2k
Blaise Bossy United States 19 2.1k 1.4× 357 0.4× 323 0.6× 647 1.7× 293 0.9× 22 3.0k
István Katona Germany 22 806 0.5× 624 0.8× 495 0.9× 634 1.7× 634 1.9× 48 2.1k
Dominik Paquet Germany 15 1.4k 0.9× 239 0.3× 369 0.6× 390 1.0× 310 0.9× 26 2.0k
Yong Ren United States 30 1.9k 1.3× 268 0.3× 787 1.4× 1.1k 2.9× 538 1.6× 57 3.2k
Rico Laage Germany 23 1.0k 0.7× 366 0.4× 362 0.6× 395 1.0× 402 1.2× 34 2.3k
Hongfeng Wang China 25 1.0k 0.7× 651 0.8× 727 1.3× 316 0.8× 289 0.8× 48 1.8k
Natalia Rodríguez‐Muela Spain 17 840 0.6× 811 1.0× 513 0.9× 253 0.7× 286 0.8× 23 1.8k
P. Rusmini Italy 33 1.6k 1.1× 657 0.8× 961 1.7× 702 1.9× 695 2.0× 59 2.9k

Countries citing papers authored by Thomas M. Durcan

Since Specialization
Citations

This map shows the geographic impact of Thomas M. Durcan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas M. Durcan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas M. Durcan more than expected).

Fields of papers citing papers by Thomas M. Durcan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas M. Durcan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas M. Durcan. The network helps show where Thomas M. Durcan may publish in the future.

Co-authorship network of co-authors of Thomas M. Durcan

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas M. Durcan. A scholar is included among the top collaborators of Thomas M. Durcan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas M. Durcan. Thomas M. Durcan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Eldeeb, Mohamed A., Andrew N. Bayne, Thomas Goiran, et al.. (2024). Tom20 gates PINK1 activity and mediates its tethering of the TOM and TIM23 translocases upon mitochondrial stress. Proceedings of the National Academy of Sciences. 121(10). e2313540121–e2313540121. 36 indexed citations
2.
Shtilbans, Alexander, et al.. (2024). Combination of tauroursodeoxycholic acid, co-enzyme Q10 and creatine demonstrates additive neuroprotective effects in in-vitro models of Parkinson’s disease. Frontiers in Neuroscience. 18. 1492028–1492028. 4 indexed citations
3.
Yaqubi, Moein, Konstantin Senkevich, Adam MacDonald, et al.. (2023). MerTK is a mediator of alpha-synuclein fibril uptake by human microglia. Brain. 147(2). 427–443. 10 indexed citations
4.
Ayoubi, Riham, Maryam Fotouhi, Joël Ryan, et al.. (2023). Antibody Characterization Report for Prolow-density lipoprotein receptor-related protein1 (LRP-1). Zenodo (CERN European Organization for Nuclear Research).
5.
Ayoubi, Riham, Maryam Fotouhi, Joël Ryan, et al.. (2023). Antibody Characterization Report for Calponin-3. Zenodo (CERN European Organization for Nuclear Research).
6.
Bédard, Nathalie, Anouar Khayachi, Julie Huynh, et al.. (2023). USP19 deubiquitinase inactivation regulates α-synuclein ubiquitination and inhibits accumulation of Lewy body-like aggregates in mice. npj Parkinson s Disease. 9(1). 157–157. 5 indexed citations
7.
Ayoubi, Riham, Joël Ryan, Michael Biddle, et al.. (2023). Scaling of an antibody validation procedure enables quantification of antibody performance in major research applications. eLife. 12. 16 indexed citations
8.
Ayoubi, Riham, Joël Ryan, Michael Biddle, et al.. (2023). Scaling of an antibody validation procedure enables quantification of antibody performance in major research applications. eLife. 12. 16 indexed citations
9.
Fotouhi, Maryam, Joël Ryan, Riham Ayoubi, et al.. (2023). Antibody Characterization Report for Valosin-containing protein VCP. Zenodo (CERN European Organization for Nuclear Research).
10.
Fotouhi, Maryam, Joël Ryan, Riham Ayoubi, et al.. (2022). Antibody Characterization Report for Ubiquilin-2. Zenodo (CERN European Organization for Nuclear Research).
11.
Ayoubi, Riham, Maryam Fotouhi, Joël Ryan, et al.. (2022). Antibody Characterization Report for QPRTase (Nicotinate-nucleotide pyrophosphorylase [carboxylating]). Zenodo (CERN European Organization for Nuclear Research).
12.
Ayoubi, Riham, Maryam Fotouhi, Joël Ryan, et al.. (2022). Antibody Characterization Report for Endothelin-converting enzyme 1. Zenodo (CERN European Organization for Nuclear Research).
13.
Soubannier, Vincent, Mathilde Chaineau, Ghazal Haghi, et al.. (2022). Rapid Generation of Ventral Spinal Cord-like Astrocytes from Human iPSCs for Modeling Non-Cell Autonomous Mechanisms of Lower Motor Neuron Disease. Cells. 11(3). 399–399. 6 indexed citations
14.
Fan, Xuelai, Esther del Cid‐Pellitero, Ebrima Gibbs, et al.. (2021). Development of an α-synuclein knockdown peptide and evaluation of its efficacy in Parkinson’s disease models. Communications Biology. 4(1). 232–232. 22 indexed citations
15.
Suarasan, Sorina, Tatu Rojalin, Rachel R. Mizenko, et al.. (2021). Identification of amyloid beta in small extracellular vesicles via Raman spectroscopy. Nanoscale Advances. 3(14). 4119–4132. 25 indexed citations
16.
Ayoubi, Riham, Maryam Fotouhi, Zhipeng You, et al.. (2021). Antibody Characterization Report for Plectin. Zenodo (CERN European Organization for Nuclear Research).
17.
Zhang, Issan, Chanshuai Han, María Lacalle‐Aurioles, et al.. (2020). Nanotherapeutic Modulation of Human Neural Cells and Glioblastoma in Organoids and Monocultures. Cells. 9(11). 2434–2434. 15 indexed citations
18.
Soubannier, Vincent, Gilles Maussion, Mathilde Chaineau, et al.. (2020). Characterization of human iPSC-derived astrocytes with potential for disease modeling and drug discovery. Neuroscience Letters. 731. 135028–135028. 37 indexed citations
19.
Laflamme, Carl, Paul M. McKeever, Rahul Kumar, et al.. (2019). Implementation of an antibody characterization procedure and application to the major ALS/FTD disease gene C9ORF72. eLife. 8. 44 indexed citations
20.
Durcan, Thomas M., et al.. (2008). Tektin 2 is required for central spindle microtubule organization and the completion of cytokinesis. The Journal of Cell Biology. 181(4). 595–603. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zheng Ying Breakdown of academic impact, for papers by Tomohiro Kabuta Breakdown of academic impact, for papers by Blaise Bossy Breakdown of academic impact, for papers by István Katona Breakdown of academic impact, for papers by Dominik Paquet Breakdown of academic impact, for papers by Yong Ren Breakdown of academic impact, for papers by Rico Laage Breakdown of academic impact, for papers by Hongfeng Wang Breakdown of academic impact, for papers by Natalia Rodríguez‐Muela Breakdown of academic impact, for papers by P. Rusmini
Rankless by CCL
2026